Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
REMS For Mavacamten Could Involve Additional Monitoring, BMS Says
User Fee Delayed; Potential For Systolic Dysfunction Needs Watching
Nov 19 2021
•
By
Mandy Jackson
The action date for mavacamten has moved from 28 January to 28 April • Source: Alamy
More from Cardiovascular
More from Therapeutic Category